Explore more publications!
St. Vincent & Grenadines Health Press
Got News to Share?

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 16, 2025

Medline Announces Pricing of Upsized Initial Public Offering
December 16, 2025

Medline Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2025

Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
MAIA Biotechnology Announces $1.51 Million Private Placement
December 16, 2025

MAIA Biotechnology Announces $1.51 Million Private Placement

Indeterminate GlobeNewswire
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
December 16, 2025

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

Indeterminate GlobeNewswire
DBV Technologies annonce des résultats préliminaires positifs dans l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques à l’arachide
December 16, 2025

DBV Technologies annonce des résultats préliminaires positifs dans l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques à l’arachide

Indeterminate GlobeNewswire
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
December 16, 2025

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference

Indeterminate GlobeNewswire
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025

FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
December 16, 2025

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025

BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
December 16, 2025

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

Indeterminate GlobeNewswire
McCarl Dental Group Announces New Name and Ownership as Shipley’s Dental Care
December 16, 2025

McCarl Dental Group Announces New Name and Ownership as Shipley’s Dental Care

Indeterminate GlobeNewswire
Valerie Health Raises $30M Series A to Bring AI Front Office to Independent Provider Groups
December 16, 2025

Valerie Health Raises $30M Series A to Bring AI Front Office to Independent Provider Groups

Indeterminate GlobeNewswire
PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"
December 16, 2025

PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore"

Indeterminate GlobeNewswire
Viral Vector Market to Grow 24.6% Annually Through 2030
December 16, 2025

Viral Vector Market to Grow 24.6% Annually Through 2030

Indeterminate GlobeNewswire
The Worksite’s Quietest Hazards Are Finally Getting the Attention—and Tools—They Deserve
December 16, 2025

The Worksite’s Quietest Hazards Are Finally Getting the Attention—and Tools—They Deserve

Indeterminate GlobeNewswire
Flexon and Mike Bako Discuss Importance of Year-End Vision Benefits and Innovation in Memory Metal Eyewear with YourUpdateTV
December 16, 2025

Flexon and Mike Bako Discuss Importance of Year-End Vision Benefits and Innovation in Memory Metal Eyewear with YourUpdateTV

Indeterminate GlobeNewswire
Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection
December 16, 2025

Tiny Health and Bristle Health Launch Groundbreaking Study on Oral-Gut Health Connection

Indeterminate GlobeNewswire
Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
December 16, 2025

Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel

Indeterminate GlobeNewswire
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions